Clinical Trials

New Search
Title   A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic HPV Associated Head and Neck Squamous Cancer
Disease/Condition   Head and Neck Cancer,Medical and Hematologic Oncology,Oncology (Medical/Hematologic),Human Papilloma Virus (HPV),Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal┬áInvestigator   Balazs Halmos, MD
Contact┬áName   Balazs Halmos, MD
Contact Email   bahalmos@montefiore.org
IRB/Protocol┬áNumber   17-11-27-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   HPV-Associated Head and Neck Cancer